N-(2-Chloro-5-methoxyphenyl)-2-methyl-5-oxo-4-propyl-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide

ID: ALA4476587

PubChem CID: 155538299

Max Phase: Preclinical

Molecular Formula: C21H25ClN2O3

Molecular Weight: 388.90

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC1C(C(=O)Nc2cc(OC)ccc2Cl)=C(C)NC2=C1C(=O)CCC2

Standard InChI:  InChI=1S/C21H25ClN2O3/c1-4-6-14-19(12(2)23-16-7-5-8-18(25)20(14)16)21(26)24-17-11-13(27-3)9-10-15(17)22/h9-11,14,23H,4-8H2,1-3H3,(H,24,26)

Standard InChI Key:  TVBFFVDMWQOGLF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   22.0642   -3.6443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0642   -4.4657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7736   -4.8743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7736   -3.2316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4830   -3.6443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4795   -4.4656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1857   -4.8791    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.8998   -4.4716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9033   -3.6503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1926   -3.2365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7736   -2.4103    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.6052   -4.8883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6132   -3.2455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6175   -2.4242    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.3228   -3.6578    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.0368   -3.2529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7458   -3.6672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4593   -3.2631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4640   -2.4409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7494   -2.0246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0388   -2.4353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1950   -2.4193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9038   -2.0127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9062   -1.1955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7403   -4.4844    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   27.7508   -1.2074    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.4592   -0.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  4 11  2  0
  8 12  1  0
  9 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 10 22  1  0
 22 23  1  0
 23 24  1  0
 17 25  1  0
 20 26  1  0
 26 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4476587

    ---

Associated Targets(Human)

FFAR3 Tchem Free fatty acid receptor 3 (304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 388.90Molecular Weight (Monoisotopic): 388.1554AlogP: 4.59#Rotatable Bonds: 5
Polar Surface Area: 67.43Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.37CX Basic pKa: CX LogP: 3.40CX LogD: 3.40
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.77Np Likeness Score: -1.14

References

1. Ulven ER, Quon T, Sergeev E, Barki N, Brvar M, Hudson BD, Dutta P, Hansen AH, Bielefeldt LØ, Tobin AB, McKenzie CJ, Milligan G, Ulven T..  (2020)  Structure-Activity Relationship Studies of Tetrahydroquinolone Free Fatty Acid Receptor 3 Modulators.,  63  (7): [PMID:32141297] [10.1021/acs.jmedchem.9b02036]

Source